Eli Lilly’s COVID-19 therapy development partner AbCellera raises $105 million

[ad_1]

Eli Lilly’s COVID-19 therapy development partner AbCellera raises $105 million

When AbCellera won a $30 million contract with the Defense Advanced Research Projects Agency to develop therapeutic countermeasures against viral outbreaks two years ago, it’s safe to assume that no one thought the technology would be so vitally important so soon. The work AbCellera was doing…
[ad_2]

Source

admin

Recommended Posts

Top Tips for Choosing the Best Software Development Company in Kenya.

May 22, 2024

Reasons Why You Should Have a Website For Your Business.

May 22, 2024

Best Domain Registration and Web Hosting Services in Nairobi, Kenya.

May 17, 2024